Skip to content

Effecct of Tilamuladi Kwath Orally and Shatavari siddha taila Matrabasti in Polycystic Ovary Syndrome (PCOS)

An Exploratory study of Tilamuladi Kwath orally and Shatavari siddha taila Matrabasti in the management of Pushpaghni(PCOS) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070689
Enrollment
30
Registered
2024-07-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N830- Follicular cyst of ovary Health Condition 2: N914- Secondary oligomenorrhea

Interventions

None listed

Sponsors

Post Graduation institute of Ayurved DSRRAU Jodhpur Rajasthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed cases of PCOS by the Rotterdam criteria- 1. Oligomenorrhea and/or anovulation. 2. Hyperandrogenism (clinical and/or bio-chemical). 3. Polycystic ovaries in USG (antral follicle count more than 12 and/or ovarian volume more than 10 ml). Age: Patients aged between 16-45 years. The patients who are fit for the Matrabasti procedure were only considered for the study. ? Patients willing for Informed consent.

Exclusion criteria

Exclusion criteria: Patients having any other disease causing oligomenorrhea and anovulation excluding PCOD on the above criteria.? ? Patients using oral contraceptive pills.? ? Pregnant and lactating women.? ? Patients suffering from thyroid abnormalities, Hyperprolactinemia, adrenal hyperplasia etc.? ? Patients with any organic reproductive system abnormalities like hydrosalpinx, endometriosis, fibroid uterus, carcinoma of reproductive organ and sexually transmitted disease (STDs), Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antigen (HBsAg).? ? Systemic disorders like-uncontrolled diabetes mellitus, chronic liver disease, renal disorder, uncontrolled hypertension, Diagnosed case of any type of malignancy. ? Patients who are contraindicated for Matrabasti like 3rd degree piles etc.

Design outcomes

Primary

MeasureTime frame
Assessment for Menstrual abnormality (Oligomenorrhea) Assessment for Hypomenorrhea? Assessment for Menorrhagia Pain associated with Menstruation Assessment of Acne (according to acne grading) Assessment of Hirsutism (on the basis of site) Assessment of stress (perceived stress scale)(PSS)Timepoint: 60 days

Secondary

MeasureTime frame
Percentage improvement in reduction of ovarian size, volume, stromal pattern? ? Percentage improvement in biochemical values.? ? Percentage improvement in hormonal assays.? ? Weight reduction as assessed by reduction in Body weight, BMI.?Timepoint: 60 days

Countries

India

Contacts

Public ContactDr ASMA SAYED

Post Graduate Institute of Ayurved DSRRAU Jodhpur Nagaur ROAD Karwar Jodhpur Rajasthan

vd_rashmi11@yahoo.com9782371381

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026